Table 1

Characteristics of the included guidelines.

Guideline identifier, year released

Guideline developer and country

Disease or condition

Guideline title

Cardiovascular disease and related condition

NCEP, 2002

(updated 2004) [10,14]

National Heart, Lung, and Blood Institute, US

Hypercholesterolemia and coronary heart disease

National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)

NICE1, 2006 [15]

National Institute for Health and Clinical Excellence, UK

Cardiovascular disease

Statins for the Prevention of Cardiovascular Events

AHA1, 2006 [16]

American Heart Association and American Stroke Association, US

Ischemic stroke

Primary Prevention of Ischemic Stroke: A Guideline From the American Heart Association/American Stroke Association Stroke Council

AHA2, 2007 [17]

American Heart Association, US

Cardiovascular disease

Evidence-Based Guidelines for Cardiovascular Disease Prevention in Women: 2007 Update

MSC1, 2008 [18]

Medical Services Commission, British Columbia, Canada

Cardiovascular disease

Cardiovascular Disease - Primary Prevention

NICE2, 2008 [19]

National Collaborating Centre for Primary Care, UK

Cardiovascular disease

Lipid Modification. Cardiovascular Risk Assessment and the Modification of Blood Lipids for the Primary and Secondary Prevention of Cardiovascular Disease

ACCP, 2008 [20]

American College of Chest Physicians, US

Coronary artery disease

The Primary and Secondary Prevention of Coronary Artery Disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)

MSC2, 2008 [21]

Medical Services Commission, British Columbia, Canada


Hypertension - Detection, Diagnosis and Management

USPSTF, 2009 [22]

U.S. Preventive Services Task Force, US

Cardiovascular disease

Aspirin for the Prevention of Cardiovascular Disease: U.S. Preventive Services Task Force Recommendation Statement

UMHS1, 2009 [23]

University of Michigan Health System, US

Coronary heart disease and stroke

Screening and Management of Lipids

ICSI, 2009 [24]

Institute for Clinical Systems Improvement, US

dyslipidemia and coronary heart disease

Lipid Management in Adults

MQIC, 2009 [25]

Michigan Quality Improvement Consortium, US


Screening and Management of Hypercholesterolemia

Cardiovascular disease and type 2 diabetes

ES, 2008 [26]

The Endocrine Society, US

Cardiovascular disease and Type 2 diabetes

Primary Prevention of Cardiovascular Disease and Type 2 Diabetes in Patients at Metabolic Risk: An Endocrine Society Clinical Practice Guideline

Type 2 diabetes

NICE3, 2008 [27]

National Clinical Guideline Centre for Acute and Chronic Conditions, UK

Type 2 diabetes

Type 2 Diabetes: National Clinical Guideline for Management in Primary and Secondary Care (update)

MSC3, 2010 [28]

Medical Services Commission, British Columbia, Canada

Type 2 diabetes

Diabetes Care

ADA, 2011 [29]

American Diabetes Association, US

Type 2 diabetes

Standards of Medical Care in Diabetes - 2011

Breast cancer

UMHS2, 2007 [30]

University of Michigan Health System, US

Breast cancer

Common Breast Problems

NSGC, 2007 [31]

National Society of Genetic Counselors, US

Breast cancer and ovarian cancer

Risk Assessment and Genetic Counseling for Hereditary Breast and Ovarian Cancer: Recommendations of the National Society of Genetic Counselors

ASCO, 2009 [32]

American Society of Clinical Oncology, US

Breast cancer

American Society of Clinical Oncology Clinical Practice Guideline Update on the Use of Pharmacologic Interventions Including Tamoxifen, Raloxifene, and Aromatase Inhibition for Breast Cancer Risk Reduction

NICE4, 2009 [33]

National Collaborating Centre for Cancer, UK

Breast cancer

Early and Locally Advanced Breast Cancer. Diagnosis and Treatment

Yu et al. BMC Medicine 2013 11:7   doi:10.1186/1741-7015-11-7

Open Data